Shares of Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $5.8930, but opened at $6.35. Oxford BioMedica shares last traded at $6.38, with a volume of 6,600 shares.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded Oxford BioMedica to a “hold” rating in a report on Wednesday, July 22nd. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of “Hold”.
View Our Latest Stock Report on Oxford BioMedica
Oxford BioMedica Stock Performance
Oxford BioMedica Company Profile
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.
See Also
- Five stocks we like better than Oxford BioMedica
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
- Cashing in on the Qubit: NVIDIA Takes the Quantum Leap
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
